Machine Learning News and Research

RSS

New AI method enhances breast cancer risk prediction from mammograms

A new study from Washington University School of Medicine in St. Louis describes an innovative method of analyzing mammograms that significantly improves the accuracy of predicting the risk of breast cancer development over the following five years.

6 Dec 2024

Understanding how the skin's neurons process social touch signals

Two types of neurons in the skin may be particularly important for how the brain interprets social contact between people, according to a new study led by Linköping University in Sweden.

6 Dec 2024

Study identifies hidden chemical risks in household products

Southwest Research Institute (SwRI) collaborated with the Environmental Protection Agency (EPA) to characterize the chemical makeup of 81 common household items. Researchers also evaluated the potential risk to users.

5 Dec 2024

Brief bursts of activity linked to heart health benefits for women

Research shows 3.4 minutes of daily VILPA is associated with a 45% reduction in major adverse cardiovascular events, highlighting sex differences in benefits.

5 Dec 2024

Children's National and FDA sign five-year collaboration for pediatric device innovation

In a significant collaboration to help advance pediatric health, Children's National Hospital and the U.S. Food and Drug Administration's (FDA) Office of Science and Engineering Laboratories (OSEL) in the Center for Devices and Radiological Health (CDRH) have signed a five-year research collaboration agreement to develop regulatory science tools (RSTs) intended to assist in the technical evaluation of pediatric and perinatal medical devices.

4 Dec 2024

Optical fiber sensing system could revolutionize monitoring of brain injuries

Fiber optics are a means of transmitting information at incredibly high speeds; however, the technology can be used for more than just providing a fast internet connection.

4 Dec 2024

AI in medicine: Revolutionary tools, uncertain results

AI decision-making systems show promise but lack consistent evidence for improving patient-relevant outcomes like mortality and quality of life. Rigorous harm-benefit assessments and transparency are needed for safe integration into healthcare.

3 Dec 2024

Study shows lasting benefits of anti-hormonal therapy in postmenopausal women

Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumors have a long-term benefit for at least 20 years, while the benefit was more short-term for younger women with similar tumor characteristics who had not yet gone through the menopause.

3 Dec 2024

Behavioral chaos in Alzheimer’s disease mice decoded by machine learning

Researchers use machine learning to identify behavioral disruptions in Alzheimer’s disease mouse models, highlighting a potential therapeutic target in fibrinogen-microglia interactions.

3 Dec 2024

Researchers aim to uncover causes of acquired hearing loss and find potential therapies

With a new five-year, $3.2 million grant from the National Institute on Deafness and Other Communications Disorders, researchers at Case Western Reserve University and Mass Eye and Ear will study what causes acquired hearing loss (AHL) and seek new ways to protect against it.

3 Dec 2024

Text message reminders fail to boost long-term medication adherence

A new study published today in JAMA reveals text message reminders for patients who delay refilling their medications didn't help improve how regularly they refilled medications over a year.

2 Dec 2024

A roadmap for understanding antimalarial drug resistance

Researchers at University of California San Diego analyzed the genomes of hundreds of malaria parasites to determine which genetic variants are most likely to confer drug resistance.

28 Nov 2024

Study finds unexpected patterns in insulin needs for type 1 diabetes

Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery systems miss vital information required for glucose regulation, a new study has found.

27 Nov 2024

Individuals with less efficient learning mechanisms benefit more from brain stimulation

As we age, our cognitive and motor functions deteriorate, which in turn affects our independence and overall quality of life.

27 Nov 2024

McMaster University develops fast and easy test for bacteria detection in fluids

A novel new test for bacteria in fluids makes it as easy as observing a color change to confirm the presence of disease-causing pathogens, promising much easier diagnostic tests and greater food safety.

26 Nov 2024

Machine learning tool detects early signs of Alzheimer's in mice

Subtle signs of Alzheimer's disease can emerge decades before a diagnosis - often in the form of irregular behaviors that reflect very early stages of brain dysfunction.

26 Nov 2024

Tagomics announces a multiomic profiling co-marketing agreement with Agilent

Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced it has entered into a strategic co-marketing agreement with Agilent Technologies, a leading tools provider in the genomics sector.

From Tagomics Ltd. 26 Nov 2024

Hamilton and Amabel James Center for AI and Human Health launches at Mount Sinai

Today, the Mount Sinai Health System, one of New York City's largest academic medical systems, announced the opening of the Hamilton and Amabel James Center for Artificial Intelligence and Human Health, which is dedicated to enhancing health care delivery through the research, development, and application of innovative artificial intelligence (AI) tools and technologies.

25 Nov 2024

Study explores factors influencing the acquisition of exercise habits in middle-aged workers

Researchers at University of Tsukuba analyzed data from middle-aged workers who had received Specific Health Guidance—a revolutionary system implemented by the Japanese Ministry of Health, Labor, and Welfare to improve lifestyle habits for individuals with metabolic syndrome and those at presumptive risk of metabolic syndrome.

23 Nov 2024

AI-designed drug ISM5939 granted IND clearance for cancer clinical trials

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has received IND clearance from FDA for ISM5939, a potential best-in-class oral small molecule inhibitor targeting ENPP1 for the treatment of solid tumors.

22 Nov 2024